Localizing haloperidol effects on sensorimotor gating in a predictive model of antipsychotic potency. (Q48406257)

11 February 2018

title

Localizing haloperidol effects on sensorimotor gating in a predictive model of antipsychotic potency. (English)

1 reference

11 February 2018

1 reference

Hart S

1

1 reference

11 February 2018

Zreik M

series ordinal

2

1 reference

11 February 2018

Carper R

series ordinal

3

1 reference

11 February 2018

Swerdlow NR

series ordinal

4

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 September 1998

1 reference

11 February 2018

Pharmacology, Biochemistry and Behavior

published in

1 reference

11 February 2018

volume

61

1 reference

11 February 2018

page(s)

113-119

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

Sensorimotor gating and habituation evoked by electro-cutaneous stimulation in schizophrenia.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900079-3

7 January 2021

Gating and habituation of the startle reflex in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900079-3

7 January 2021

Hippocampal modulation of acoustic startle and prepulse inhibition in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900079-3

7 January 2021

Effects of D3/D2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900079-3

7 January 2021

Antipsychotic potential of CCK-based treatments: an assessment using the prepulse inhibition model of psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900079-3

7 January 2021

Presidential Address, 1974. The more or less startling effects of weak prestimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900079-3

7 January 2021

Startle gating deficits occur across prepulse intensities in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900079-3

7 January 2021

Acoustic and temporal factors in the evocation of startle

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900079-3

7 January 2021

Deficient sensorimotor gating after 6-hydroxydopamine lesion of the rat medial prefrontal cortex is reversed by haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900079-3

7 January 2021

Quinolinic acid lesions of the ventral striatum reduce sensorimotor gating of acoustic startle in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900079-3

7 January 2021

Reduced prepulse inhibition after electrolytic lesions of nucleus accumbens subregions in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900079-3

7 January 2021

Role of the strychnine-insensitive glycine binding site in the nucleus accumbens and anterodorsal striatum in sensorimotor gating: a behavioral and microdialysis study.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900079-3

7 January 2021

Dopaminergic stimulation disrupts sensorimotor gating in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900079-3

7 January 2021

A note on the connections and development of the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900079-3

7 January 2021

Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900079-3

7 January 2021

Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900079-3

7 January 2021

Regionally selective effects of intracerebral dopamine infusion on sensorimotor gating of the startle reflex in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900079-3

7 January 2021

Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900079-3

7 January 2021

Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900079-3

7 January 2021

Increased sensitivity to the sensorimotor gating-disruptive effects of apomorphine after lesions of medial prefrontal cortex or ventral hippocampus in adult rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900079-3

7 January 2021

Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900079-3

7 January 2021

The ventral subiculum modulation of prepulse inhibition is not mediated via dopamine D2 or nucleus accumbens non-NMDA glutamate receptor activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900079-3

7 January 2021

Intra-accumbens infusion of quinpirole impairs sensorimotor gating of acoustic startle in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900079-3

7 January 2021

Sensorimotor gating in rats is regulated by different dopamine-glutamate interactions in the nucleus accumbens core and shell subregions.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900079-3

7 January 2021

Changes in the acoustic startle response and prepulse inhibition of acoustic startle in rats after local injection of pertussis toxin into the ventral tegmental area.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900079-3

7 January 2021

Prepulse inhibition in the rat is regulated by ventral and caudodorsal striato-pallidal circuitry

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900079-3

7 January 2021

10.1016/S0091-3057(98)00079-3

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

9715813

1 reference

11 February 2018